We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Pre-Operative Cardiac Sonography May Predict Outcomes

By MedImaging International staff writers
Posted on 03 Aug 2016
Print article
Image: A summary of the study (Photo courtesy of Yuichi Notomi / Hayama).
Image: A summary of the study (Photo courtesy of Yuichi Notomi / Hayama).
A new study suggests that a simple pre-operative echocardiographic assessment of left ventricular (LV) torsion could predict the outcomes of mitral valve surgery.

Researchers at Hayama Heart Center (Kanagawa, Japan) examined 50 consecutive patients with nonischemic, chronic, secondary severe mitral regurgitation (NICSMR). All patients had advanced heart failure (HF) symptoms, and had received the maximum guideline-directed medical therapy for more than six months. The patients were divided into three groups: preserved LV torsion, lost LV torsion, or patients with a wide QRS who received cardiac resynchronization therapy (CRT). All patients received either mitral valve repair or mitral valve replacement.

Two years after surgery, 19 of the patients had died. The researchers found that LV torsional profile predicted post-surgical outcomes in NICSMR patients with a narrow QRS band, but not in those with a wide QRS band. Patients who received CRT prior to mitral surgery showed significantly worse two-year survival than those who received the procedure during mitral surgery. However, the two groups had similar LV torsion. The study was published on June 27, 2016, in JACC: Basic to Translational Science.

“These findings show that lost left ventricular torsion and previously administered cardiac resynchronization therapy appear to be markers of poor survival after mitral surgery in patients with NICSMR,” said lead author Yuichi Notomi, MD, of the division of cardiovascular imaging. “We also found that reverse remodeling was only observed in patients with preserved left ventricular torsion, demonstrating that lost left ventricular torsion and wide QRS were markers of no reverse remodeling viability.”

“Mechanistically, this study suggests that the loss of torsion in patients with heart failure may reflect irreversible structural damage to the heart which would prevent the heart from recovering after corrective surgery,” said Douglas Mann, MD, editor-in-chief of JACC: Basic to Translational Science. “If correct, this will have much broader implications than improvement after mitral valve surgery, since it may predict which patients with heart failure may get better on medications.”

Related Links:
Hayama Heart Center


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound System
P25 Elite
New
Thyroid Shield
Standard Thyroid Shield
Laptop Ultrasound Scanner
PL-3018

Print article

Channels

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.